Form D · Biotechnology

Calithera Biosciences, Inc.

South San Francisco, CA · CIK 0001496671

Offering snapshot reported Jul 31, 2014 · SEC filing

Reported sold
$16M
Offering amount: $30M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 1, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 31, 2014Initial$15,999,998No comparison19SEC filing
Oct 25, 2013Initial$27,150,000No comparison17SEC filing
Dec 31, 2012Initial$1,999,999No comparison4SEC filing
May 31, 2012Amendment$7,999,999$4,000,000vs Nov 10, 20116SEC filing
Nov 10, 2011Initial$3,999,999No comparison6SEC filing
Jul 16, 2010Initial$9,999,999No comparison7SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-222059
Sale and issuance of Series D Preferred Stock as convertible into shares of Common Stock

Source: Form D, filed Jul 31, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ralph E. Christoffersen Director
Jonathan Drachman Director
Jean M. George Director
Laurence Lasky Director
Susan M. Molineaux Director, Executive
Deepa Pakianathan Director
Deepika Pakianathan Director
William Waddill Executive
James Wells Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
343 Oyster Point Blvd. Suite 200
South San Francisco, CA, 94080